A letter to the editor clarifies the renal dosing of apixaban (Eliquis) for venous thromboembolism, based on the AMPLIFY trial and the manufacturer's recommendation. The authors recommend no dose adjustment for apixaban in patients with impaired renal function, but careful monitoring.
The recommended dose of ELIQUIS is 10 mg taken orally twice daily for 7 days, followed by 5 mg taken orally twice daily. Prevention of Recurrent DVT and PE The recommended dose of ELIQUIS is 2.5 mg taken orally twice daily after at least 6 months of treatment for DVT or PE. Use in Renal Impairment
NOAC metabolism and use for patients with hepatic or renal impairment. Apixaban (Eliquis), dabigatran (Pradaxa) and rivaroxaban (Xarelto) vary in their degrees
The recommended dose of Apixaban (Eliquis) is 2.5 mg taken orally twice daily after at least 6 months of treatment for DVT or PE. Renal Impairment. Prevention
Apixaban (Eliquis), dabigatran (Pradaxa) and rivaroxaban (Xarelto) vary in their degrees of renal excretion, half-lives, metabolism and bioavailability (see
Lovenox (VNA will only come once a day and this medication is dosed BID) Eliquis (Apixaban) /- 10 mg BID loading dose x 7 days then 5mg BID. Renal
Do not change your dose or stop taking ELIQUIS unless your doctor tells you to. What if I miss a dose of ELIQUIS? If you miss a dose of ELIQUIS, take it as
ELIQUIS does not require a dose adjustment in patients with mild-to-moderate renal impairment, but is not recommended in patients with CrCl 15 ml/min or on dialysis. Liver function testing should be performed prior to initiating ELIQUIS and yearly or more frequently in some patients.
Lovenox (VNA will only come once a day and this medication is dosed BID) Eliquis (Apixaban) /- 10 mg BID loading dose x 7 days then 5mg BID. Renal
Comments